{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T02:45:58Z","timestamp":1775529958669,"version":"3.50.1"},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2013,1,2]],"date-time":"2013-01-02T00:00:00Z","timestamp":1357084800000},"content-version":"vor","delay-in-days":3036,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Andrology"],"published-print":{"date-parts":[[2004,9,10]]},"abstract":"<jats:p><jats:bold>ABSTRACT:<\/jats:bold>The objective of this study was to detect a therapy for idiopathic and varicocele\u2010associated oligoasthenospermia (OAT). Idiopathic and varicocele OAT patients were randomized into 3 groups. Each group was composed of varying degrees of left varicoceles (graded into 5 grades with echo\u2010color Doppler) and of idiopathic OATs. Group 1 used a placebo, group 2 used oral<jats:sc>l<\/jats:sc>carnitine (2 g\/d) + acetyl\u2010<jats:sc>l<\/jats:sc>carnitine (1 g\/d), group 3 used<jats:sc>l<\/jats:sc>carnitine\/acetyl\u2010<jats:sc>l<\/jats:sc>\u2010carnitine + 1 \u00d7 30\u2010mg cinnoxicam suppository every 4 days. Drugs were administered for 6 months. The groups were composed as follows: group 1, 71 varicoceles and 47 idiopathic OATs; group 2, 62 varicoceles and 39 idiopathic OATs; group 3, 62 varicoceles and 44 idiopathic OATs. Sperm concentration, motility, and morphology before during and after treatments were assessed. Pregnancy rates and side effects were recorded. Group 1 did not have modified sperm patterns during treatment. Group 2 had significantly increased sperm patterns at 3 and 6 months into therapy in idiopathic patients and in patients with grades I, II, and III varicocele, but not in grades IV and V. Group 3 had significantly increased sperm parameters in all patients, with the exception of grade V varicocele. Group 3 sperm patterns proved significantly higher during therapy than group 2. All sperm patterns fell to baseline after therapy suspension. Minor side effects occurred. Pregnancy rates were 1.7% (group 1), 21.8% (group 2), and 38.0% (group 3) (P &lt; .01).<jats:sc>l<\/jats:sc>\u2010Carnitine\/acetyl\u2010<jats:sc>l<\/jats:sc>\u2010carnitine + cinnoxicam suppositories proved a reliable treatment for low\u2010grade varicoceles and idiopathic OATs.<\/jats:p>","DOI":"10.1002\/j.1939-4640.2004.tb02853.x","type":"journal-article","created":{"date-parts":[[2015,12,16]],"date-time":"2015-12-16T20:11:52Z","timestamp":1450296712000},"page":"761-770","source":"Crossref","is-referenced-by-count":118,"title":["Cinnoxicam and<scp>l<\/scp>\u2010Carnitine\/Acetyl\u2010<scp>l<\/scp>\u2010Carnitine Treatment for Idiopathic and Varicocele\u2010Associated Oligoasthenospermia"],"prefix":"10.1002","volume":"25","author":[{"given":"Giorgio","family":"Cavallini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Pia","family":"Ferraretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Gianaroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Biagiotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,1,2]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(03)01123-3"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/01485010290099183"},{"key":"e_1_2_5_4_1","volume-title":"Reproductive Medicine. Molecular, Cellular and Genetic Fundamentals","author":"Fauser CJM Bart","year":"2003"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1987.tb00220.x"},{"key":"e_1_2_5_6_1","first-page":"1","article-title":"Farmacologia clinica dei farmaci anti\u2010infiammatori non steroidei. Un nuovo derivato benzotiazinico: il Cinnoxicam","volume":"79","author":"Bert\u00e8 F.","year":"1998","journal-title":"Minerva Med"},{"key":"e_1_2_5_7_1","first-page":"270","article-title":"Correlazione tra lipofilia del principio attivo ed attivit\u00e0 anti\u2010infiammatoria per via topica","volume":"131","author":"Berti M.","year":"1992","journal-title":"Boll Chim Farm"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(02)00277-9"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0010-7824(02)00303-7"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1985.03350360059018"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-410X.2003.04136.x"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1054\/plef.2000.0174"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/HUMREP\/10.6.1457"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)37684-1"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13503-9"},{"key":"e_1_2_5_16_1","volume-title":"Farmaannuario","author":"Federazione Nazionale Farmacisti (Federfarma)","year":"2003"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)02966-1"},{"key":"e_1_2_5_18_1","first-page":"1439","article-title":"The effects of prostaglandin synthetase inhibitor on male infertility","volume":"30","author":"Fuse H.","year":"1984","journal-title":"Hinyokika Kiyo"},{"key":"e_1_2_5_19_1","first-page":"981","volume-title":"Terapia Medica Pratica","author":"Gatti E.","year":"1980"},{"key":"e_1_2_5_20_1","volume-title":"Varicocele 2000","author":"Gattuccio F.","year":"2000"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64388-1"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/01485010290099200"},{"key":"e_1_2_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)46043-7"},{"key":"e_1_2_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)55925-1"},{"key":"e_1_2_5_25_1","first-page":"59","volume-title":"Hum Reprod","author":"Jarow P.","year":"2001"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/13.3.596"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04679-4"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.7.1785"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1530\/jrf.0.0820353"},{"key":"e_1_2_5_30_1","first-page":"353","article-title":"In vitro effects of l\u2010carnitine on the inhibition of sperm motility induced by nonsteroidal anti\u2010inflammatory drug","volume":"151","author":"Mangano NG","year":"2000","journal-title":"Clin Ther"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(95)02556-1"},{"key":"e_1_2_5_32_1","first-page":"64","article-title":"Effect of Y virilin on male infertility","volume":"43","author":"Rege NN","year":"1997","journal-title":"J Postgrad Med"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.4.1028"},{"key":"e_1_2_5_34_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/j.1939-4640.2002.tb02324.x","article-title":"Oxidative stress and male infertility: from research to clinical practice","volume":"23","author":"Sale RA","year":"2002","journal-title":"J Androl"},{"key":"e_1_2_5_35_1","volume-title":"Statistical Methods","author":"Snedecor GW","year":"1987"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.11.2338"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)03229-0"},{"key":"e_1_2_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1989.tb01312.x"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.1992.tb01129.x"},{"key":"e_1_2_5_40_1","volume-title":"WHO Laboratory Manual for the Examination of Human Semen and Semen\u2010Cervical Mucus Interaction","author":"Organization World Health","year":"1999"},{"key":"e_1_2_5_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)66149-4"},{"key":"e_1_2_5_42_1","first-page":"131","article-title":"Magnesium orotate suppelemntation for idiopathic infertile male patients: a randomized placebo controlled clinical pilot study","volume":"16","author":"Zawackzi Z.","year":"2003","journal-title":"Magnes Res"}],"container-title":["Journal of Andrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1939-4640.2004.tb02853.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1939-4640.2004.tb02853.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T03:50:34Z","timestamp":1718250634000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/j.1939-4640.2004.tb02853.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9,10]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2004,9,10]]}},"alternative-id":["10.1002\/j.1939-4640.2004.tb02853.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1939-4640.2004.tb02853.x","archive":["Portico"],"relation":{},"ISSN":["0196-3635","1939-4640"],"issn-type":[{"value":"0196-3635","type":"print"},{"value":"1939-4640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9,10]]}}}